Aggressive B-Cell Lymphomas: Experts Discuss New Care Standards and Evolving Treatment Strategies

Download these slides from a live symposium at ASH 2022 to gain more insight into the role of prognostic and predictive biomarkers in the management of patients with MCL.

John P. Leonard, MD
Program Director Released: December 12, 2022

Download these slides from a live symposium at ASH 2022 to gain more insight into the biology, prognosis, and selection of initial therapy for patients with DLBCL.

Laurie H. Sehn, MD, MPH Released: December 12, 2022

Download these slides from a live symposium at ASH 2022 to gain more insight into the optimal management of primary refractory and relapsed/refractory DLBCL.

John Allan, MD Released: December 12, 2022

Download this short summary slideset covering the key points from a live symposium to gain more insight into the diagnosis and optimal management of MCL and DLBCL.

John P. Leonard, MD
Program Director John Allan, MD Laurie H. Sehn, MD, MPH Released: December 16, 2022

Watch this on-demand webcast from a December 2022 symposium featuring John P. Leonard, MD; John Allan, MD; and Laurie H. Sehn, MD, MPH, on the use of new and evolving treatment strategies in the management of patients with mantle cell lymphoma and diffuse large B-cell lymphoma.

John P. Leonard, MD
Program Director John Allan, MD Laurie H. Sehn, MD, MPH Physicians: maximum of 2.0 AMA PRA Category 1 Credits™ Released: January 30, 2023 Expired: January 29, 2024

In this commentary, expert faculty address frequently asked questions about the selection and sequencing of therapies for patients with aggressive B-cell lymphomas.

John P. Leonard, MD
Program Director John Allan, MD Laurie H. Sehn, MD, MPH Released: January 31, 2023